Compared to the vehicle group, administration of PF-03084014 alone decreased Ki-67 expression by 22% and microvessel density by 69%; administration of sorafenib alone decreased Ki-67 expression by 23% and microvessel density by 54.4% in HCC-spheroid tumors. Here, MKI67 is linked to hepatocellular carcinoma.